Atlas Trials

Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects

Clinical trial NCT01519531 · COMPLETED

Trial details

NCT number
NCT01519531
Sponsor
Madrigal Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug Safety
Start date
2012-01-01
Primary completion
2012-11-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.